ARCHIVES

White House Yet To Name NCAB, Cancer Panel Members

This article is from The Cancer Letter archive.

Vol. 37 No. 06 | February 11, 2011

Download PDF Visit The Full Archive

Related Articles

The Lancet Oncology Retracts Potti Paper, NEJM Doesn’t

February 4, 2011

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

October 18, 2002

FDA Describes Meeting With NCI In “Limited” Memo

May 7, 1976

Contract Awards Sole Source Negotiations

January 13, 1978

NCI/NTP Studies Found EDB Carcinogenic, But Risk To Human Said Not Conclusive

March 23, 1984

Dept. of Defense opens program announcements for prostate cancer research.

December 10, 2004